DAVID KREMPA: Open Payments
NPI 1780753038 · JAMESTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,134 in 62 payments from 12 companies in 2025. Trend: 2023 $1,665 · 2024 $1,729 · 2025 $1,134
Food & beverage: $1,134
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 21 | $280 |
| Lilly USA, LLC | 11 | $250 |
| Novo Nordisk Inc | 10 | $208 |
| AstraZeneca Pharmaceuticals LP | 5 | $114 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| PFIZER INC. | 2 | $49 |
| ABBVIE INC. | 2 | $48 |
| GlaxoSmithKline, LLC. | 3 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: OTEZLA, MOUNJARO, JARDIANCE, EVENITY, AIRSUPRA, LEQVIO, VRAYLAR, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
